Patients and carers

  • Email
  • Help

Information for you

On this page, you will find information on the Agency’s activities that are most relevant to patients and carers, including news, and events.

You can contribute to the Agency’s work by responding to public consultations.

Learn more about how Patients and carers are actively involved in the work of the Agency.

Featured information

  • Patients’ and healthcare professionals’ meeting

    The joint meeting of patients’ and healthcare professionals’ working parties took place in March. Participants discussed interaction with patients in 2015, measuring the impact of pharmacovigilance activities, the ICH guideline on good clinical practice and access to EudraVigilance data. EMA will publish the meeting minutes and presentations.

  • information on medicines

    Communication and information on medicines

    Patients and healthcare professionals took part in a session on communication and information on medicines, focusing on how information on medicines is produced and used. Participants considered survey results to identify the current landscape, then discussed opportunities for improvement and future research areas. EMA expects to publish a report on the session.

  • patients and consumers

    Training and resources

    EMA updated its online content for patients and consumers, adding information on Training and resources including EMA and external training opportunities, links to relevant workshops and materials and a series of short videos called EMA Basics. These cover the role of EMA, the centralised procedure and how EMA works with patients. More videos will follow in 2016.

  • bacteria

    Antimicrobial resistance

    Antimicrobial resistance is a growing problem in humans and in animals. EMA is concerned about the development of antimicrobial resistance, particularly resistance to antibiotics. Read more about EMA’s activities in relation to antimicrobial resistance.

News for patients and carers

Events of interest

  • 17/05/2016 - 18/05/2016

    EMA

    EMA public workshop on extrapolation of efficacy and safety in medicine development

    In 2013, the European Medicines Agency (EMA) published a concept paper on extrapolation of efficacy and safety in medicine development. It aims to discuss the need and possibility of developing a framework for extrapolation approaches that are considered scientifically valid and reliable to support medicine authorisation. The framework will set out a structured approach for each extrapolation exercise, in order to improve interactions with stakeholders and to standardise decision making across committees. Further to the extrapolation expert meeting that took place in September 2015, EMA will publish a reflection paper on extrapolation across age groups that will include considerations specific to global product development and licensing of paediatric medicines. This workshop will present the reflection paper and seek feedback from developers. ... Read more

  • 30/06/2016

    EMA

    Workshop on single-arm trials (SAT) in oncology

    Single-arm trials (SATs) have led to regulatory approval of oncology products in case of dramatic activity in well-defined populations with high unmet medical need. Further, when randomized-controlled trials are not possible, SATs augmented with statistical approaches may become the standard basis of evidence of efficacy for new applications. However, what constitutes dramatic activity and high unmet medical need is often debated and there is no regulatory guidance on cancer drug development in these situations and how to manage the remaining uncertainties optimally. This workshop, co-organised with the European Society for Medical Oncology (ESMO), will debate the experience gained with these types of approvals, the strengths and weaknesses of different approaches, explore the views of different stakeholders and underlying principles, and will discuss the need and appropriateness for further regulatory guidance. ... Read more

  • 09/03/2016

    EMA

    European Medicines Agency (EMA) Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting

    This is a joint meeting with representatives from patients’, consumers’ and healthcare professionals’ organisations. Participants will be updated on the 2015 EMA annual report, the PCWP and HCPWP 2016-2019 mandates and elections of co-chairs, updated EMA dedicated webpages for patients and healthcare professionals, European Union and global initiatives, pharmacovigilance activities and feedback from the scientific committees. ... Read more

  • 27/03/2017 - 28/03/2017

    HMPC

    Committee for Herbal Medicinal Products (HMPC): 27-28 March 2017

    The Committee on Herbal Medicinal Products (HMPC) is the committee that is responsible for preparing the Agency’s opinions on questions relating to herbal medicines. ... Read more

  • 29/01/2018 - 30/01/2018

    HMPC

    Committee for Herbal Medicinal Products (HMPC): 29-30 January 2018

    The Committee on Herbal Medicinal Products (HMPC) is the committee that is responsible for preparing the Agency’s opinions on questions relating to herbal medicines. ... Read more

  • See all Events of interest

Information for:

Find information for...

Medicines for elderly

ADR website spotlight

FAQ spotlight